1. Home
  2. CINGW vs FHN Comparison

CINGW vs FHN Comparison

Compare CINGW & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • FHN
  • Stock Information
  • Founded
  • CINGW N/A
  • FHN 1864
  • Country
  • CINGW United States
  • FHN United States
  • Employees
  • CINGW 13
  • FHN N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • FHN Major Banks
  • Sector
  • CINGW Health Care
  • FHN Finance
  • Exchange
  • CINGW Nasdaq
  • FHN Nasdaq
  • Market Cap
  • CINGW N/A
  • FHN 10.4B
  • IPO Year
  • CINGW 2021
  • FHN N/A
  • Fundamental
  • Price
  • CINGW $0.05
  • FHN $20.14
  • Analyst Decision
  • CINGW
  • FHN Buy
  • Analyst Count
  • CINGW 0
  • FHN 13
  • Target Price
  • CINGW N/A
  • FHN $18.31
  • AVG Volume (30 Days)
  • CINGW N/A
  • FHN 6.9M
  • Earning Date
  • CINGW N/A
  • FHN 10-16-2024
  • Dividend Yield
  • CINGW N/A
  • FHN 2.96%
  • EPS Growth
  • CINGW N/A
  • FHN N/A
  • EPS
  • CINGW N/A
  • FHN 1.37
  • Revenue
  • CINGW N/A
  • FHN $3,071,000,000.00
  • Revenue This Year
  • CINGW N/A
  • FHN N/A
  • Revenue Next Year
  • CINGW N/A
  • FHN $2.23
  • P/E Ratio
  • CINGW N/A
  • FHN $14.80
  • Revenue Growth
  • CINGW N/A
  • FHN 0.03
  • 52 Week Low
  • CINGW N/A
  • FHN $11.87
  • 52 Week High
  • CINGW N/A
  • FHN $20.53
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • FHN 73.08
  • Support Level
  • CINGW N/A
  • FHN $19.86
  • Resistance Level
  • CINGW N/A
  • FHN $20.53
  • Average True Range (ATR)
  • CINGW 0.00
  • FHN 0.45
  • MACD
  • CINGW 0.00
  • FHN 0.24
  • Stochastic Oscillator
  • CINGW 0.00
  • FHN 89.12

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The regional bank is responsible for roughly 65% of its revenue, while capital markets make a 25% contribution. The remainder is split between the firm's non-strategic (wind-down) and corporate operations. First Horizon concentrates on offering a variety of banking products mainly in its home state, where it has the second- largest deposit franchise with a 13% deposit market share.

Share on Social Networks: